So again, that will put an end to our second panel.
I want to thank all of our witnesses for participating today. We shall excuse you.
Please remain on, members, and we'll just move on into our business.
What we need to do today is approve the subcommittee report that was sent to you earlier today and that briefly summarizes the discussions we had Wednesday evening.
You've all had a chance to look at the report. We just need your blessing on that as the main committee. Are we good with that report from the subcommittee? Does anybody have any issues?
It looks like we're all good on that, and the main focus of the meeting is also to provide direction to the analysts to prepare a draft letter on BRM. We agreed to set aside an hour this coming Wednesday—